Diabetes, Vol 44, Issue 10 1161-1164, Copyright © 1995 by American Diabetes Association
Treatment of IFN-gamma transgenic mice with anti-IFN-gamma reveals the remodeling capacity of the adult pancreas
D Gu, L Molony, T Krahl and N Sarvetnick
Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037, USA.
Pancreatic expression of gamma-interferon (IFN-gamma) initiates a cascade
of pathogenic changes that include pancreatic inflammation, islet cell
destruction, hyperglycemia, and islet regeneration. In this study, we
explore the developmental plasticity of the adult pancreas and particularly
its ability to return to normoglycemia and to remodel itself from an
advanced pathogenic state. This was approached by treating adult transgenic
mice with a pulse of anti-IFN-gamma antibody and determining the functional
and morphological status of the pancreas. We demonstrated that
anti-IFN-gamma antibody administration led to the reduction of
hyperglycemic blood glucose levels in transgenic mice. We also observed
that the pancreas returned from a profoundly perturbed state toward
normality. Analysis of the mitotic index indicated that cell proliferation
previously associated with islet cell regeneration was greatly reduced
after anti-IFN-gamma administration. Our results highlight the ability of
the adult pancreas to remodel itself and return from a complex pathological
state to normalcy once the trophic signal inducing this pathology is
removed. These data also suggest that anti-IFN-gamma administration may
have important clinical implications for treatment of chronic pancreatitis
in humans.